Result
€404,128 ▲ 227%
The result rose in 2025 from €123,399 to €404,128.
MedXPress.Pro
Lifetime
9 annual accounts with figures on one time axispeak €787,167 (2025)
€787,167▲ 115%
lowest -€179,020 (2021)
€404,128▲ 227%
peak €384,554 (2025)
€384,554▲ €404,128
€1.1m▲ 141%
Board2 names since 2017
2 directorsAdmir HADZIC and 1 other
Documentsfilings and deeds
30-07-20261 days before the deadline
2025micro format
Gross margin from €365,421 to €787,167Result from €123,399 to €404,128Equity from -€19,575 to €384,554Debts from €443,882 to €1.1mInvestments €540,000Cash from €88,259 to €6,161
Key points
from the 2025 annual accountsTurnover
≈ €1.2m estimated
The micro format states no turnover.
Debts
€1.1m ▲ 141%
Debts rose by €627,931 in 2025.
Staff
4 employees on 31-12-2025
In 2025, 1 person joined and 2 left.
Filings
9 annual accounts since 2017
The last five annual accounts were filed 1 to 7 days before the end of the period.
Position in the sector
€404,128
Higher net result than 95% of companies in office administrative support. Sector median €16,240 · 9,678 companies.
Checked score
92
Excellent
Financially stronger than 58% of micro companies in office administrative support (NACE 82)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 12,669 companies (NACE 82, micro).
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.5%
01-2025: 0.5%● unchanged vs 12-2024
02-2025: 0.5%● unchanged vs 01-2025
03-2025: 0.5%● unchanged vs 02-2025
04-2025: 0.5%● unchanged vs 03-2025
05-2025: 0.5%● unchanged vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.5%● unchanged vs 06-2025highest value
08-2025: 0.2%▼ -0.3 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.3%▲ +0.1 percentage points vs 04-2026
06-2026: 0.2%▼ -0.1 percentage points vs 05-2026
07-2026: 0.3%▲ +0.1 percentage points vs 06-2026
08-2026: 0.2%▼ -0.1 percentage points vs 07-2026
09-2026: 0.1%▼ -0.1 percentage points vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026lowest value
11-2026: 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Liquidity: current ratio 1.22, cash €6,161, halved
lowers risk
Size: total assets €1.5m
Sector: Office administrative, office support and other business support activities (NACE 82)
Figures for financial year 2025 (filed on 02-08-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, micro). It does better than 33% of them on solvency, 14% on liquidity, 87% on profitability and 99% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 6,713 companies had the same profile as MedXPress.Pro has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of MedXPress.Pro itself is lower: 0.1% within 12 months. It rests on far more data about MedXPress.Pro than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,713 companies, not a prediction for MedXPress.Pro. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.22 (0.85 in 2024), below the usual 1.5. Short-term debt is 49.3% and cash 0.4% of total assets. 73.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
1 day early
2024
7 days early
2023
6 days early
2022
5 days early
2021
6 days early
2020
2 days early
2019
3 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 4 days before the deadline. In the sector (NACE 82), the median for financial year 2024 was 7 days before the deadline, and 35% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
2 managers resigning, 2 directors reappointed
Resignations: Admir HADZIC (niet statutaire zaakvoerder, thans bestuurder) and Catherine VANDEPITTE (niet statutaire zaakvoerder, thans bestuurder) · Reappointments: Admir HADZIC (director) and Catherine VANDEPITTE (director) · Director discharge: Admir HADZIC · General meeting of 23-11-2023 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0673704095
Incorporation
published on 03-04-2017 · Gazette deed
First establishment
Slachthuislaan 1, Leuven
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MedXPress.Pro Leuven | €1.5m | €0.8m | 26.4% | - |
| MAGNOTRADE Antwerp | €1.3m | €0.8m | 1.5% | - |
| BruNetto Asse | €1.1m | €0.8m | 57.6% | - |
| Industrious BRUS The Artist Saint-Josse-ten-Noode | €1.9m | €0.8m | 34.0% | 6 |
| MINGLE GROUP Watermael-Boitsfort | €1.4m | €1.1m | 92.0% | - |
| AE Conseil Andenne | €1.5m | €1.0m | 9.3% | 6.3 |
| Untranslate Kontich | €1.0m | €0.6m | 79.0% | 6.9 |
These companies have the same main activity as MedXPress.Pro: office administrative and support services (NACE 82100). They are comparable in size and age: total assets between €1m and €1.9m, founded between 2014 and 2019.
Official details
Source: KBO- Status
- Active since 30-03-2017Normal situation
- Registered office
- 12 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 6 November 2026.
- Activity
- Office administrative and support servicesNACE 82100and 1 other
- Establishment unit
- 2.341.925.4383000 Leuven, since 30-03-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 31-10-2023
Annual accounts 2025
- €1.5m▲ 243%
- Employeeson 31-12-2025
- 4▼ 20.0%
- Filing
- Filed on 30-07-2026, 1 day before the end of the filing period
Insights on MedXPress.Pro
MedXPress.Pro files the micro format. That format states no turnover. The gross margin rose from -€5,476 in 2017 to €787,167 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MedXPress.Pro
- What is the company number of MedXPress.Pro?
- The company number of MedXPress.Pro is 0673.704.095. The VAT number is the same number with BE in front: BE 0673.704.095.
- Where is MedXPress.Pro based?
- The registered office is at Slachthuislaan 1, 3000 Leuven.Company details
- What does MedXPress.Pro do?
- According to the KBO register, the main activity is office administrative and support services (NACE 82100).
- What is the legal form of MedXPress.Pro?
- MedXPress.Pro is a private limited company (BV).
- When was MedXPress.Pro founded?
- MedXPress.Pro was founded on 30-03-2017.
- Is MedXPress.Pro still active?
- Yes, MedXPress.Pro is an active enterprise in the KBO register.
- How many employees does MedXPress.Pro have?
- MedXPress.Pro had an average of 4.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of MedXPress.Pro?
- The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €787,167 and 62 comparable companies (NACE 82). It probably lies between €980,000 and €2.1m.
- Is MedXPress.Pro profitable?
- In financial year 2025, MedXPress.Pro made a profit of €404,128.
- Where can I find the annual accounts of MedXPress.Pro?
- MedXPress.Pro filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MedXPress.Pro due?
- MedXPress.Pro must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.